Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)

Primary cervical screening with high risk human papillomavirus testing: observational study

(2019) Matejka Rebolj et al.   BMJ-British Medical Journal

Clinical impact and cost-effectiveness of primary cytology versus human papillomavirus testing for cervical cancer screening in England

(2019) Irenjeet Bains et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study

(2019) Tim Palmer et al.   BMJ-British Medical Journal

Methylation in predicting progression of untreated high-grade cervical intraepithelial neoplasia

(2019) Karolina Louvanto et al.   CLINICAL INFECTIOUS DISEASES

Age-specific HPV type distribution in high-grade cervical disease in screened and unvaccinated women

(2019) Karoliina Aro et al.   GYNECOLOGIC ONCOLOGY

Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines

(2018) Kine Pedersen et al.   EUROPEAN JOURNAL OF CANCER

Quality of life assumptions determine which cervical cancer screening strategies are cost-effective

(2018) Inge M.C.M. de Kok et al.   INTERNATIONAL JOURNAL OF CANCER

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months

(2018) Gina Suzanne Ogilvie et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Impact of the National HPV Vaccination Program in England Using the Bivalent HPV Vaccine: Surveillance of Type-Specific HPV in Young Females, 2010–2016

(2018) David Mesher et al.   JOURNAL OF INFECTIOUS DISEASES

Self-sampling coupled to the detection of HPV 16 and 18 E6 protein: A promising option for detection of cervical malignancies in remote areas

(2018) Kátia Luz Torres et al.   PLoS One

Socio-economic variations in anticipated adverse reactions to testing HPV positive: Implications for the introduction of primary HPV-based cervical screening

(2018) Mairead O'Connor et al.   PREVENTIVE MEDICINE

Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses

(2018) Marc Arbyn et al.   BMJ-British Medical Journal

Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial

(2017) Thomas C. Wright et al.   GYNECOLOGIC ONCOLOGY

What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study

(2017) Rebecca Landy et al.   INTERNATIONAL JOURNAL OF CANCER

Role of quantitative p16INK4A mRNA assay and digital reading of p16INK4A immunostained sections in diagnosis of cervical intraepithelial neoplasia

(2017) Nataša Vasiljević et al.   INTERNATIONAL JOURNAL OF CANCER

Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18

(2017) Long Fu Xi et al.   INTERNATIONAL JOURNAL OF CANCER

Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women

(2017) Murat Gultekin et al.   INTERNATIONAL JOURNAL OF CANCER

4-Valent Human Papillomavirus (4vHPV) Vaccine in Preadolescents and Adolescents After 10 Years

(2017) Daron G. Ferris et al.   PEDIATRICS

Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference

(2017) Paolo Giorgi Rossi et al.   PREVENTIVE MEDICINE

Ten-year immune persistence and safety of the HPV-16/18 AS04-adjuvanted vaccine in females vaccinated at 15-55 years of age

(2017) Tino F. Schwarz et al.   Cancer Medicine

Impact of variations in triage cytology interpretation on human papillomavirus–based cervical screening and implications for screening algorithms

(2016) Guglielmo Ronco et al.   EUROPEAN JOURNAL OF CANCER

Commercially available molecular tests for human papillomaviruses (HPV): 2015 update

(2016) Mario Poljak et al.   JOURNAL OF CLINICAL VIROLOGY

Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus

(2016) Jane J. Kim et al.   JNCI-Journal of the National Cancer Institute

Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus

(2016) Jane J. Kim et al.   JNCI-Journal of the National Cancer Institute

Systematic review of model-based cervical screening evaluations

(2015) Diana Mendes et al.   BMC CANCER

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

(2015) M. Arbyn et al.   CLINICAL MICROBIOLOGY AND INFECTION

Comparing the performance ofFAM19A4methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study)

(2015) Roosmarijn Luttmer et al.   INTERNATIONAL JOURNAL OF CANCER

Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland

(2014) K G J Pollock et al.   BRITISH JOURNAL OF CANCER

The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds

(2014) Henry C Kitchener et al.   HEALTH TECHNOLOGY ASSESSMENT

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis

(2014) Marc Arbyn et al.   LANCET ONCOLOGY

Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening

(2014) Warner K. Huh et al.   Applied Health Economics and Health Policy

HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology

(2013) Attila T Lorincz et al.   INTERNATIONAL JOURNAL OF CANCER

2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors

(2013) L. Stewart Massad et al.   Journal of Lower Genital Tract Disease

Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study

(2013) Hans Ikenberg et al.   JNCI-Journal of the National Cancer Institute

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

(2013) Guglielmo Ronco et al.   LANCET

Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer

(2012) Peng Guan et al.   INTERNATIONAL JOURNAL OF CANCER

A population-based study of human papillomavirus genotype prevalence in the United States: Baseline measures prior to mass human papillomavirus vaccination

(2012) Cosette M. Wheeler et al.   INTERNATIONAL JOURNAL OF CANCER

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

(2012) Marc Arbyn et al.   VACCINE

Nucleic Acid Tests for the Detection of Alpha Human Papillomaviruses

(2012) Mario Poljak et al.   VACCINE

Viral Load in the Natural History of Human Papillomavirus Type 16 Infection: A Nested Case–Control Study

(2011) Long Fu Xi et al.   JOURNAL OF INFECTIOUS DISEASES

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study

(2011) Philip E Castle et al.   LANCET ONCOLOGY

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition--Summary Document

(2010) M. Arbyn et al.   ANNALS OF ONCOLOGY

Commercially available assays for multiplex detection of alpha human papillomaviruses

(2010) Mario Poljak et al.   Expert Review of Anti-Infective Therapy

High-risk human papillomavirus DNA test and p16INK4a in the triage of LSIL: A prospective diagnostic study

(2010) I. Tsoumpou et al.   GYNECOLOGIC ONCOLOGY

Liquid Compared With Conventional Cervical Cytology

(2010) Marc Arbyn et al.   OBSTETRICS AND GYNECOLOGY

The Expected Impact of HPV Vaccination on the Accuracy of Cervical Cancer Screening: The Need for a Paradigm Change

(2009) Eduardo L. Franco et al.   ARCHIVES OF MEDICAL RESEARCH

p16INK4a immunostaining in cytological and histological specimens from the uterine cervix: A systematic review and meta-analysis

(2009) I. Tsoumpou et al.   CANCER TREATMENT REVIEWS

HPV Screening for Cervical Cancer in Rural India

(2009) Rengaswamy Sankaranarayanan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

(2008) Chris J.L.M. Meijer et al.   INTERNATIONAL JOURNAL OF CANCER

Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination

(2008) J. D. Goldhaber-Fiebert et al.   JNCI-Journal of the National Cancer Institute

Results at Recruitment From a Randomized Controlled Trial Comparing Human Papillomavirus Testing Alone With Conventional Cytology as the Primary Cervical Cancer Screening Test

(2008) G. Ronco et al.   JNCI-Journal of the National Cancer Institute